1. Home
  2. BZFD vs MURA Comparison

BZFD vs MURA Comparison

Compare BZFD & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BuzzFeed Inc.

BZFD

BuzzFeed Inc.

HOLD

Current Price

$1.01

Market Cap

40.6M

ML Signal

HOLD

Logo Mural Oncology plc

MURA

Mural Oncology plc

HOLD

Current Price

$2.03

Market Cap

36.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZFD
MURA
Founded
2006
2013
Country
United States
Ireland
Employees
N/A
N/A
Industry
Movies/Entertainment
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
40.6M
36.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BZFD
MURA
Price
$1.01
$2.03
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
427.9K
224.8K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$184,927,000.00
N/A
Revenue This Year
$0.51
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$394.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.84
$0.95
52 Week High
$4.40
$4.74

Technical Indicators

Market Signals
Indicator
BZFD
MURA
Relative Strength Index (RSI) 42.92 40.39
Support Level $0.95 $2.06
Resistance Level $1.33 $2.10
Average True Range (ATR) 0.09 0.01
MACD 0.04 -0.01
Stochastic Oscillator 28.09 25.00

Price Performance

Historical Comparison
BZFD
MURA

About BZFD BuzzFeed Inc.

BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

Share on Social Networks: